These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 1929607)

  • 21. Differential expression and tissue compartmentalization of the inflammatory response following thermal injury.
    Schwacha MG; Schneider CP; Chaudry IH
    Cytokine; 2002 Mar; 17(5):266-74. PubMed ID: 12027408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the parasite enzyme, hypodermin A, on bovine lymphocyte proliferation and interleukin-2 production via the prostaglandin pathway.
    Nicolas-Gaulard I; Moire N; Boulard C
    Immunology; 1995 May; 85(1):160-5. PubMed ID: 7635517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of NFAT and AP-1 in PGE2-mediated T cell suppression in burn injury.
    Choudhry MA; Mao H; Haque F; Khan M; Fazal N; Sayeed MM
    Shock; 2002 Sep; 18(3):212-6. PubMed ID: 12353920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
    Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
    Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burn wound infection-induced myeloid suppression: the role of prostaglandin E2, elevated adenylate cyclase, and cyclic adenosine monophosphate.
    Gamelli RL; He LK; Liu H; Ricken JD
    J Trauma; 1998 Mar; 44(3):469-74. PubMed ID: 9529173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The increased release of prostaglandin E2 by Kupffer cells from burned guinea pigs.
    Ogle CK; Wu JZ; Wood S; Ogle JD; Alexander JW; Warden GD
    J Burn Care Rehabil; 1990; 11(4):287-94. PubMed ID: 2401682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
    Murray JL; Dowd J; Hersh EM
    J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.
    Faist E; Markewitz A; Fuchs D; Lang S; Zarius S; Schildberg FW; Wachter H; Reichart B
    Ann Surg; 1991 Sep; 214(3):264-73; discussion 274-5. PubMed ID: 1929608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous prostaglandin E2 in interleukin 1 production by peripheral blood monocytes from patients with rheumatoid arthritis.
    Yamamura M; Nishiya K; Ota Z
    Acta Med Okayama; 1990 Feb; 44(1):13-20. PubMed ID: 2330842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
    Balch CM; Dougherty PA; Tilden AB
    Ann Surg; 1982 Dec; 196(6):645-50. PubMed ID: 6216863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma production in atopic dermatitis: a role for prostaglandins?
    Byron KA; Liberatos S; Varigos GA; Wootton AM
    Int Arch Allergy Immunol; 1992; 99(1):50-5. PubMed ID: 1483067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of protein kinase C in cyclic AMP-mediated suppression of T-lymphocyte activation following burn injury.
    Schwacha MG; Ayala A; Cioffi WG; Bland KI; Chaudry IH
    Biochim Biophys Acta; 1999 Sep; 1455(1):45-53. PubMed ID: 10524228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase.
    Hahn EL; Clancy KD; Tai HH; Ricken JD; He LK; Gamelli RL
    J Trauma; 1998 May; 44(5):777-81; discussion 781-2. PubMed ID: 9603077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 suppresses the expression and release of beta 2-microglobulin from mitogen-activated normal human mononuclear cells.
    Tsai CY; Yu CL; Hsieh SC; Liao TS; Lin WM
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Sep; 56(3):143-51. PubMed ID: 8854435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of prostaglandin E2 by macrophages in uraemia.
    Langhoff E; Blaehr H; Ladefoged J
    Nephrol Dial Transplant; 1991; 6(12):966-70. PubMed ID: 1798596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.